Choline kinase alpha impairment overcomes TRAIL resistance in ovarian cancer cells.
Andrea RizzoAlessandro SattaGiulia GarroneAdalberto CavalleriAlessandra NapoliFrancesco RaspagliesiMariangela FiginiLoris De CeccoEgidio IorioAntonella TomassettiMezzanzanica DeliaMarina BagnoliPublished in: Journal of experimental & clinical cancer research : CR (2021)
Our findings suggest that ChoKα/CHKA impairment, by restoring drug-induced or receptor-mediated cell death, could be a suitable therapeutic strategy to be used in combination with chemotherapeutics or immunomodulators to improve OC patients' outcome.